Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9721)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Colecchia A, Schiumerini R, Cucchetti A, Cescon M, Taddia M, Marasco G, Festi D. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol 2014; 20(20): 5935-5950 [PMID: 24876717 DOI: 10.3748/wjg.v20.i20.5935] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/5935.htm |
| Number | Citing Articles |
| 1 |
Yu Rim Lee, Soo Young Park, Seung Up Kim, Se Young Jang, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Keun Hur. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. Journal of Gastroenterology and Hepatology 2017; 32(5): 1079 doi: 10.1111/jgh.13644
|
| 2 |
Yuying Chen, Jia Chen, Yu Zhang, Zhi Lin, Meng Wang, Lifei Huang, Mengqi Huang, Mimi Tang, Xiaoqi Zhou, Zhenpeng Peng, Bingsheng Huang, Shi-Ting Feng. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging. Journal of Hepatocellular Carcinoma 2021; : 795 doi: 10.2147/JHC.S313879
|
| 3 |
Yu-Chao Wang, Jin-Chiao Lee, Tsung-Han Wu, Chih-Hsien Cheng, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee. Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02425-w
|
| 4 |
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B. Clinical and Molecular Hepatology 2019; 25(4): 390 doi: 10.3350/cmh.2018.0103
|
| 5 |
Han Wang, You-Wen Qian, Meng-Chao Wu, Wen-Ming Cong. Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion. Journal of Gastrointestinal Surgery 2020; 24(12): 2737 doi: 10.1007/s11605-019-04251-8
|
| 6 |
Kung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, Yu-De Chu, Chih-Lang Lin, Wey-Ran Lin, Ya-Hui Huang, Tong-Hung Wang, Rong-Nan Chien, Tsung-Hui Hu, Chau-Ting Yeh. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01761-1
|
| 7 |
Rikiya Yamashita, Jin Long, Atif Saleem, Daniel L. Rubin, Jeanne Shen. Deep learning predicts postsurgical recurrence of hepatocellular carcinoma from digital histopathologic images. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81506-y
|
| 8 |
Huan-Hsien Kuo, Ruey-Jen Lin, Jung-Tung Hung, Chung-Bao Hsieh, Tsai-Hsien Hung, Fei-Yun Lo, Ming-Yi Ho, Chau-Ting Yeh, Yen-Lin Huang, John Yu, Alice L. Yu. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11136-w
|
| 9 |
David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim. Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis. Digestive Diseases and Sciences 2019; 64(12): 3660 doi: 10.1007/s10620-019-05701-8
|
| 10 |
Mohamed A. Hassan-Kadle, Marian Muse Osman, Esra Keles, Hasan Huseyin Eker, Kursad Nuri Baydili, Hussein Mahdi Ahmed, Abdirahman Abdikadir Osman, Dirk Uhlmann. Clinical Characteristics of Patients with Hepatocellular Carcinoma: A Single-Center 3-Year Experience from Somalia. International Journal of Hepatology 2022; 2022: 1 doi: 10.1155/2022/3370992
|
| 11 |
Amos Otedo, Kenneth O. Simbiri, Vincent Were, Omollo Ongati, Benson A. Estambale. Risk factors for liver Cancer in HIV endemic areas of Western Kenya. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0214-5
|
| 12 |
Haohan Liu, Yongcong Yan, Jianhong Lin, Chuanchao He, Hao Liao, Huoming Li, Zhenyu Zhou, Jie Wang, Kai Mao, Zhiyu Xiao. Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis. Molecular Therapy - Nucleic Acids 2022; 29: 788 doi: 10.1016/j.omtn.2022.08.008
|
| 13 |
Jianhua Gong, Junyi Wang, Tianpin Liu, Jun Hu, Jun Zheng. lncRNA FEZF1‑AS1 contributes to cell proliferation, migration and invasion by sponging miR‑4443 in hepatocellular carcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9585
|
| 14 |
Lei Zhang, Zhimin Geng, Yong Wan, Fandi Meng, Xiankui Meng, Lin Wang. Functional analysis of miR-767-5p during the progression of hepatocellular carcinoma and the clinical relevance of its dysregulation. Histochemistry and Cell Biology 2020; 154(2): 231 doi: 10.1007/s00418-020-01878-6
|
| 15 |
Liming Wang, Weihu Wang, Weiqi Rong, Zhuo Li, Fan Wu, Yunhe Liu, Yiling Zheng, Kai Zhang, Tana Siqin, Mei Liu, Bo Chen, Jianxiong Wu. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07087-7
|
| 16 |
Jinpo Wang, Rongfeng Huang, Yuehong Huang, Yunxin Chen, Fenglin Chen. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis. Advances in Therapy 2021; 38(6): 3342 doi: 10.1007/s12325-021-01762-2
|
| 17 |
Wei Cheng, Ziwei Cheng, Dongwei Xing, Minguang Zhang. Asparagus Polysaccharide Suppresses the Migration, Invasion, and Angiogenesis of Hepatocellular Carcinoma Cells Partly by Targeting the HIF-1α/VEGF Signalling Pathway In Vitro. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/3769879
|
| 18 |
Akitoshi Douhara, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Kaji, Hideto Kawaratani, Kosuke Takeda, Yasushi Okura, Hiroaki Takaya, Ryuichi Noguchi, Norihisa Nishimura, Kenichiro Seki, Shinya Sato, Yasuhiko Sawada, Junichi Yamao, Akira Mitoro, Masakazu Uejima, Tsuyoshi Mashitani, Naotaka Shimozato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Takuya Kubo, Hitoshi Yoshiji. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization. Oncology Letters 2017; 14(3): 3028 doi: 10.3892/ol.2017.6489
|
| 19 |
Jianqiang Cai, Jianjun Zhao, Defang Liu, Huangfan Xie, Hailong Qi, Junfan Ma, Zhongjie Sun, Hong Zhao. Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.781029
|
| 20 |
Ja-Der Liang, Xiao-Ou Ping, Yi-Ju Tseng, Guan-Tarn Huang, Feipei Lai, Pei-Ming Yang. Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods. Computer Methods and Programs in Biomedicine 2014; 117(3): 425 doi: 10.1016/j.cmpb.2014.09.001
|
| 21 |
Weiyi Zhu, Xiangjun Dong, Na Tian, Zijuan Feng, Weihui Zhou, Weihong Song. CSTB accelerates the progression of hepatocellular carcinoma via the ERK/AKT/mTOR signaling pathway. Heliyon 2024; 10(1): e23506 doi: 10.1016/j.heliyon.2023.e23506
|
| 22 |
Mei Liu, Liming Wang, Hongxia Zhu, Weiqi Rong, Fan Wu, Shufang Liang, Ningzhi Xu, Jianxiong Wu. A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients. Translational Oncology 2016; 9(3): 167 doi: 10.1016/j.tranon.2016.03.002
|
| 23 |
Zorays Moazzam, Henrique A. Lima, Laura Alaimo, Yutaka Endo, Chanza F. Shaikh, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma. Surgery 2022; 172(5): 1448 doi: 10.1016/j.surg.2022.07.019
|
| 24 |
Hui Zhao, Ye Hua, Zhihua Lu, Shen Gu, Laifa Zhu, Yuan Ji, Yudong Qiu, Tu Dai, Huihan Jin. Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion. Oncotarget 2017; 8(37): 61203 doi: 10.18632/oncotarget.18049
|
| 25 |
Huaying Xie, Xuhua Xiao, Xiaoyuan Yi, Kunzhao Huang, Liyan Wang. Cell-Membrane-Coated Metal–Organic Framework Nanocarrier Combining Chemodynamic Therapy for the Inhibition of Hepatocellular Carcinoma Proliferation. Pharmaceutics 2024; 16(5): 619 doi: 10.3390/pharmaceutics16050619
|
| 26 |
Roberto Santambrogio, Matteo Barabino, Savino Bruno, Nicolò Mariani, Nirvana Maroni, Emanuela Bertolini, Giuseppe Franceschelli, Enrico Opocher. Surgical Resection vs. Ablative Therapies Through a Laparoscopic Approach for Hepatocellular Carcinoma: a Comparative Study. Journal of Gastrointestinal Surgery 2018; 22(4): 650 doi: 10.1007/s11605-017-3648-y
|
| 27 |
Gustavo Pilotto D. SÁ, Fernando P. P. VICENTINE, Alcides A. SALZEDAS-NETTO, Carla Adriana Loureiro de MATOS, Luiz R. ROMERO, Dario F. P. TEJADA, Paulo Celso Bosco MASSAROLLO, Gaspar J. LOPES-FILHO, Adriano M. GONZALEZ. LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2016; 29(4): 240 doi: 10.1590/0102-6720201600040007
|
| 28 |
Ferhat Can Piskin, Huseyin Tugsan Balli, Kivilcim Eren Erdoğan, Sinan Sozutok, Kairgeldy Aikimbaev. Whole tumor volumetric ADC analysis: relationships with histopathological differentiation of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5180 doi: 10.1007/s00261-021-03240-3
|
| 29 |
Elton DAJTI, Giovanni MARASCO, Federico RAVAIOLI, Luigina V. ALEMANNI, Benedetta ROSSINI, Luigi COLECCHIA, Amanda VESTITO, Davide FESTI, Antonio COLECCHIA. The role of liver and spleen elastography in advanced chronic liver disease. Minerva Gastroenterology 2021; 67(2) doi: 10.23736/S2724-5985.20.02793-2
|
| 30 |
Yi Jin, Jianning Chen, Zhiying Feng, Wenzhe Fan, Yu Wang, Jiaping Li, Dayue Tong. The expression of Survivin and NF-κB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma. Tumor Biology 2014; 35(10): 9905 doi: 10.1007/s13277-014-2279-0
|
| 31 |
Cunhua Shao, Gongpan Liu, Xiaobin Zhang, Anyun Li, Xingjun Guo. <p>Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766</p>. OncoTargets and Therapy 2020; : 3013 doi: 10.2147/OTT.S243736
|
| 32 |
Meng-jun Qiu, Li Zhang, Yao-bing Chen, Li-sheng Zhu, Bin Zhang, Qiu-ting Li, Sheng-li Yang, Zhi-fan Xiong. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology 2021; 137: 106037 doi: 10.1016/j.biocel.2021.106037
|
| 33 |
Yao Zhang, Sichi Kuang, Qungang Shan, Dailin Rong, Zhongping Zhang, Hao Yang, Jun Wu, Jingbiao Chen, Bingjun He, Ying Deng, Neil Roberts, Jun Shen, Sudhakar K. Venkatesh, Jin Wang. Can IVIM help predict HCC recurrence after hepatectomy?. European Radiology 2019; 29(11): 5791 doi: 10.1007/s00330-019-06180-1
|
| 34 |
Feng Wang, Hou-Qun Ying, Bang-Shun He, Yu-Qin Pan, Qi-Wen Deng, Hui-Ling Sun, Jie Chen, Xian Liu, Shu-Kui Wang. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015; 6(10): 7899 doi: 10.18632/oncotarget.3219
|
| 35 |
Marie Lequoy, Christèle Desbois‐Mouthon, Dominique Wendum, Vandana Gupta, Jean‐Luc Blachon, Olivier Scatton, Sylvie Dumont, Mireille Bonnemaire, Fabien Schmidlin, Olivier Rosmorduc, Laetitia Fartoux. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis. Histopathology 2017; 70(3): 492 doi: 10.1111/his.13034
|
| 36 |
Yujia Zhao, Linyong Wu, Hui Qin, Qing Li, Chanliang Shen, Yun He, Hong Yang. Preoperative combi-elastography for the prediction of early recurrence after curative resection of hepatocellular carcinoma. Clinical Imaging 2021; 79: 173 doi: 10.1016/j.clinimag.2021.05.020
|
| 37 |
Jérôme Ghidaglia, Nicolas Golse, Alina Pascale, Mylène Sebagh, Florent L. Besson. 18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.924824
|
| 38 |
Shengpan Jiang, Xiaoqing Gao, Yueli Tian, Jie Chen, Yichun Wang, Yaqun Jiang, Yong He. The potential of 18F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantation. Abdominal Radiology 2024; 49(5): 1444 doi: 10.1007/s00261-023-04166-8
|
| 39 |
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
|
| 40 |
Sheng Zhang, Jie Li, Pingguo Liu, Jianfeng Xu, Wenxiu Zhao, Chengrong Xie, Zhenyu Yin, Xiaomin Wang. Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression. Oncotarget 2015; 6(13): 11074 doi: 10.18632/oncotarget.3570
|
| 41 |
Vladimir M. Subbotin. Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targets. Drug Discovery Today 2018; 23(3): 548 doi: 10.1016/j.drudis.2018.01.020
|
| 42 |
Jia-Yi Wu, Zhen-Yu Yin, Yan-Nan Bai, Yu-Feng Chen, Song-Qiang Zhou, Shuang-Jia Wang, Jian-Yin Zhou, Yi-Nan Li, Fu-Nan Qiu, Bin Li, Mao-Lin Yan. Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of Hepatocellular Carcinoma 2021; : 1233 doi: 10.2147/JHC.S332420
|
| 43 |
Xiyin Huang, Juanyong Pan, Gaoxiong Wang, Tiancong Huang, Chengzong Li, Yanjun Wang, Xinfeng Li. UNC5B-AS1 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis. Cell Cycle 2021; 20(20): 2114 doi: 10.1080/15384101.2021.1962632
|
| 44 |
Henrique Gama, Ronniel Albuquerque, David Campos Wanderley, Marcelo Antônio Pascoal Xavier, Fernanda Maria Farage Osório, Cláudia Alves Couto, Teresa Cristina de Abreu Ferrari, Agnaldo S Lima, Paulo Henrique Costa Diniz, Paula Vieira Teixeira Vidigal. Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 91 doi: 10.2147/JHC.S389836
|
| 45 |
Yi-Mei Xiong, Fang Zhou, Jia-Wen Zhou, Fei Liu, Si-Qi Zhou, Bo Li, Zhong-Jian Liu, Yang Qin. Aberrant Expressions of PSMD14 in Tumor Tissue are the Potential
Prognostic Biomarkers for Hepatocellular Carcinoma after Curative
Resection. Current Genomics 2023; 24(6): 368 doi: 10.2174/0113892029277262231108105441
|
| 46 |
Xiao Fu, Yixuan Yang, Dazhi Zhang. Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma. Liver International 2022; 42(3): 696 doi: 10.1111/liv.15115
|
| 47 |
Hyun Joon An, Woo Young Shin, Keon-Young Lee, Seung-Ik Ahn. A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2015; 19(3): 89 doi: 10.14701/kjhbps.2015.19.3.89
|
| 48 |
Dong Kyu Kim, Chansik An, Yong Eun Chung, Jin-Young Choi, Joon Seok Lim, Mi-Suk Park, Myeong-Jin Kim. Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival. Radiology 2019; 293(3): 594 doi: 10.1148/radiol.2019190414
|
| 49 |
Roland Syha, Gerd Grözinger, Ulrich Grosse, Michael Maurer, Lars Zender, Marius Horger, Konstantin Nikolaou, Dominik Ketelsen. Parenchymal Blood Volume Assessed by C-Arm–Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma. Investigative Radiology 2016; 51(2): 121 doi: 10.1097/RLI.0000000000000215
|
| 50 |
Wei Song, Jingjing Zhang, Jianbo Zhang, Miaomiao Sun, Qingxin Xia. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0857-3
|
| 51 |
Fan Hsiu-Lung, Hsieh Chung-Bao, Kuo Shih-Ming, Chen Teng-Wei. Risk Factors for Early and Late Recurrence in Hepatocellular Carcinoma after Liver Transplantation. Journal of Medical Sciences 2021; 41(6): 273 doi: 10.4103/jmedsci.jmedsci_160_20
|
| 52 |
Cristina-Paula Ursu, Andra Ciocan, Ștefan Ursu, Răzvan Alexandru Ciocan, Claudia Diana Gherman, Ariana-Anamaria Cordoș, Dan Vălean, Rodica Sorina Pop, Luminița Elena Furcea, Bogdan Procopeț, Horia Ștefănescu, Emil Ioan Moiș, Nadim Al Hajjar, Florin Graur. Prognostic Indicators of Overall Survival in Hepatocellular Carcinoma Patients Undergoing Liver Resection. Cancers 2024; 16(7): 1427 doi: 10.3390/cancers16071427
|
| 53 |
Jin-Chiao Lee, Chih-Hsien Cheng, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee. Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma. Medicine 2019; 98(11): e14827 doi: 10.1097/MD.0000000000014827
|
| 54 |
HongWei Xu, Fei Liu, XiangYong Hao, YongGang Wei, Bo Li, TianFu Wen, WenTao Wang, JiaYin Yang. Laparoscopically anatomical versus non-anatomical liver resection for large hepatocellular carcinoma. HPB 2020; 22(1): 136 doi: 10.1016/j.hpb.2019.06.008
|
| 55 |
Christian P. Strassburg. HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?. Visceral Medicine 2016; 32(4): 263 doi: 10.1159/000446385
|
| 56 |
Weimin Liu, Dailin Rong, Jie Zhu, Yuanqiang Xiao, Linqi Zhang, Ying Deng, Jun Chen, Meng Yin, Sudhakar K. Venkatesh, Richard L. Ehman, Jin Wang. Diagnostic accuracy of 3D magnetic resonance elastography for assessing histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest. Abdominal Radiology 2021; 46(10): 4601 doi: 10.1007/s00261-021-03150-4
|
| 57 |
Charlotte Costentin, Etienne Audureau, Young Nyun Park, Serena Langella, Eric Vibert, Alexis Laurent, François Cauchy, Olivier Scatton, Mircea Chirica, Rami Rhaiem, Emmanuel Boleslawski, Luca di Tommaso, Alessandro Ferrero, Hirohisa Yano, Jun Akiba, Matteo Donadon, Martina Nebbia, Olivier Detry, Pierre Honoré, Marcello Di Martino, Lilian Schwarz, Louise Barbier, Jean‐Charles Nault, Hyungjin Rhee, Chetana Lim, Raffaele Brustia, Valérie Paradis, Catherine Guettier, Brigitte Le Bail, Shinya Okumura, Jean‐Frédéric Blanc, Julien Calderaro. ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma. Liver International 2023; 43(11): 2538 doi: 10.1111/liv.15683
|
| 58 |
Yao-Li Chen, Ping-Yi Lin, Ying-Zi Ming, Wei-Chieh Huang, Rong-Fu Chen, Po-Ming Chen, Pei-Yi Chu. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3460-9
|
| 59 |
Shichao Ding, Yanfeng Jin, Qingzhi Hao, Yanmeng Kang, Ruiping Ma. LncRNA BCYRN1/miR-490-3p/POU3F2, served as a ceRNA network, is connected with worse survival rate of hepatocellular carcinoma patients and promotes tumor cell growth and metastasis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-019-1081-x
|
| 60 |
Junjie Liu, Jinming Zhao, H. A. O. Gu, Zhiqiang Zhu. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis. Minimally Invasive Therapy & Allied Technologies 2022; 31(3): 332 doi: 10.1080/13645706.2020.1839775
|
| 61 |
Valeria Abbate, Margherita Marcantoni, Felice Giuliante, Fabio Vecchio, Ilaria Gatto, Caterina Mele, Antonio Saviano, Damiano Arciuolo, Eleonora Gaetani, Maria Ferrari, Igor Giarretta, Francesco Ardito, Laura Riccardi, Alberto Nicoletti, Francesca Ponziani, Antonio Gasbarrini, Maurizio Pompili, Roberto Pola. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection. International Journal of Molecular Sciences 2017; 18(5): 1043 doi: 10.3390/ijms18051043
|
| 62 |
Santosh Sarnaik, Dhananjay Bhatane, Sharon Rose Pamshong, Amit Alexander. Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles. Journal of Drug Delivery Science and Technology 2024; 94: 105504 doi: 10.1016/j.jddst.2024.105504
|
| 63 |
Emile B. Veenstra, Simeon J. S. Ruiter, Robbert J. de Haas, Koert P. de Jong, Paola A. Erba, Rudi A. J. O. Dierckx, Walter Noordzij. A dual-tracer approach using [11C]CH and [18F]FDG in HCC clinical decision making. EJNMMI Research 2023; 13(1) doi: 10.1186/s13550-023-01024-y
|
| 64 |
Sheng-lan Yang, Ying-ying Luo, Min Chen, Yan-ping Zhou, Fu-rong Lu, Dan-fang Deng, Yan-ran Wu. A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy. HPB 2017; 19(10): 835 doi: 10.1016/j.hpb.2017.06.002
|
| 65 |
Qian Liu, Chunfu Zhu, Yanfen Dong. LncRNA TCTN2 Promotes the Malignant Development of Hepatocellular
Carcinoma via Regulating mIR-1285-3p/ARF6 Axis. Recent Patents on Anti-Cancer Drug Discovery 2023; 18(4): 517 doi: 10.2174/1574892818666221019163656
|
| 66 |
Yibin Wang, Jintang Liao, Wenjun Qi, Lulu Xie, Yueyi Li. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection. Ultrasound in Medicine & Biology 2016; 42(5): 1042 doi: 10.1016/j.ultrasmedbio.2015.12.010
|
| 67 |
Hend Ibrahim Shousha, Rabab Fouad, Tamer Mahmoud Elbaz, Dina Sabry, Mohamed Mahmoud Nabeel, Ahmed Hosni Abdelmaksoud, Aisha Mahmoud Elsharkawy, Zeinab Abdellatif Soliman, Ghada Habib, Ashraf Omar Abdelaziz. Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers. Arab Journal of Gastroenterology 2020; 21(2): 95 doi: 10.1016/j.ajg.2020.04.002
|
| 68 |
Hui Zhao, Chuang Chen, Xu Fu, Xiaopeng Yan, Wenjun Jia, Liang Mao, Huihan Jin, Yudong Qiu. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection. Oncotarget 2017; 8(3): 5474 doi: 10.18632/oncotarget.12547
|
| 69 |
Lijie Song, Weijie Zhang, Zhiwei Chang, Yanfeng Pan, Hong Zong, Qingxia Fan, Liuxing Wang. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells. Medical Science Monitor 2017; 23: 1741 doi: 10.12659/MSM.900296
|
| 70 |
Jinyu He, Jiao Yu. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A. Bioscience Reports 2019; 39(11) doi: 10.1042/BSR20192550
|
| 71 |
Haohan Liu, Yongcong Yan, Ruibing Chen, Mengdi Zhu, Jianhong Lin, Chuanchao He, Bingchao Shi, Kai Wen, Kai Mao, Zhiyu Xiao. Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01216-9
|
| 72 |
Lorrane Viana, Rui Caetano Oliveira, Ricardo Martins, Henrique Alexandrino, Maria Augusta Cipriano, José Guilherme Tralhão. Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping. Gastrointestinal Disorders 2024; 6(2): 402 doi: 10.3390/gidisord6020027
|
| 73 |
Michael L Caparelli, Nathan J Roberts, Timothy S Braverman, Robert M Stevens, Edward R Broun, Shyam Allamaneni. Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma. World Journal of Hepatology 2016; 8(23): 994-998 doi: 10.4254/wjh.v8.i23.994
|
| 74 |
Fengxiang Shi, Zheng Zhou, Xiaozhun Huang, Qing Liu, Aihua Lin. Is Anatomical Resection Necessary For Early Hepatocellular Carcinoma? A Single Institution Retrospective Experience. Future Oncology 2019; 15(17): 2041 doi: 10.2217/fon-2019-0117
|
| 75 |
Wan-Yuan Chen, Yong-Kang Diao, Hang-Dong Jia, Lei Liang, Tian Yang. Association Between Olfactomedin 4 and Postoperative Prognosis in Patients With Early-Stage Hepatocellular Carcinoma. Clinical and Translational Gastroenterology 2020; 11(6): e00163 doi: 10.14309/ctg.0000000000000163
|
| 76 |
Amanda Vestito, Elton Dajti, Fabio Cortellini, Marco Montagnani, Franco Bazzoli, Rocco Maurizio Zagari. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis. Ultraschall in der Medizin - European Journal of Ultrasound 2023; 44(03): e139 doi: 10.1055/a-1657-8825
|
| 77 |
Gauri Mishra, Anouk Dev, Eldho Paul, Wa Cheung, Jim Koukounaras, Ashu Jhamb, Ben Marginson, Beng Ghee Lim, Paul Simkin, Adina Borsaru, James Burnes, Mark Goodwin, Vivek Ramachandra, Manfred Spanger, John Lubel, Paul Gow, Siddharth Sood, Alexander Thompson, Marno Ryan, Amanda Nicoll, Sally Bell, Ammar Majeed, William Kemp, Stuart K. Roberts. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06806-4
|
| 78 |
Chenyu Shen, Wenxi Jiang, Ruiqing Chen, Lingbing Li, Yunbo Wu, Long Tan, Yadong Chen, Weiqiang Zhang, Zhijun Wang. Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study. Journal of Cancer Research and Clinical Oncology 2024; 150(9) doi: 10.1007/s00432-024-05949-2
|
| 79 |
Aida Sabaté-Llobera, Judit Mestres-Martí, Gabriel Reynés-Llompart, Laura Lladó, Kristel Mils, Teresa Serrano, Montserrat Cortés-Romera, Esther Bertran, Isabel Fabregat, Emilio Ramos. 2-[18F]FDG PET/CT as a Predictor of Microvascular Invasion and High Histological Grade in Patients with Hepatocellular Carcinoma. Cancers 2021; 13(11): 2554 doi: 10.3390/cancers13112554
|
| 80 |
Yunfei Zhang, Chun Yang, Ruofan Sheng, Yongming Dai, Mengsu Zeng. Predicting the recurrence of hepatocellular carcinoma (≤ 5 cm) after resection surgery with promising risk factors: habitat fraction of tumor and its peritumoral micro-environment. La radiologia medica 2023; 128(10): 1181 doi: 10.1007/s11547-023-01695-6
|
| 81 |
Takatsugu Matsumoto, Taku Aoki, Takayuki Shimizu, Kyung Hwa Park, Takayuki Shiraki, Yuhki Sakuraoka, Shozo Mori, Yukihiro Iso, Mitsuru Ishizuka, Keiichi Kubota. Prognostic significance of preoperative hyaluronic acid level in patients with hepatocellular carcinoma. HPB 2022; 24(4): 525 doi: 10.1016/j.hpb.2021.09.001
|
| 82 |
Guifang Yu, Jieheng Lin, Chengcheng Liu, Kailian Hou, Min Liang, Boyun Shi. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16781-9
|
| 83 |
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?. Medical Hypotheses 2019; 126: 109 doi: 10.1016/j.mehy.2019.03.019
|
| 84 |
Sascha Vaghiri, Dimitrios Prassas, Onur Mustafov, Sinan Kalmuk, Wolfram Trudo Knoefel, Nadja Lehwald-Tywuschik, Andrea Alexander, Levent Dizdar. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution. BMC Surgery 2024; 24(1) doi: 10.1186/s12893-024-02399-y
|
| 85 |
Wan-Joon Kim, Tae-Wan Lim, Pyoung-Jae Park, Sae-Byeol Choi, Wan-Bae Kim. Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection. The International Journal of Biological Markers 2019; 34(2): 123 doi: 10.1177/1724600819834306
|
| 86 |
Jingbiao Chen, Jing Zhou, Sichi Kuang, Yao Zhang, Sidong Xie, Bingjun He, Ying Deng, Hao Yang, Qungang Shan, Jun Wu, Claude B. Sirlin, Jin Wang. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma. American Journal of Roentgenology 2019; 213(4): 821 doi: 10.2214/AJR.19.21168
|
| 87 |
Bong Kyung Bae, Hee Chul Park, Gyu Sang Yoo, Moon Seok Choi, Joo Hyun Oh, Jeong Il Yu. The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2022; 14(9): 2081 doi: 10.3390/cancers14092081
|
| 88 |
Kosei Takagi, Takahito Yagi, Yuzo Umeda, Susumu Shinoura, Ryuichi Yoshida, Daisuke Nobuoka, Takashi Kuise, Hiroyuki Araki, Toshiyoshi Fujiwara. Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma. World Journal of Surgery 2017; 41(9): 2353 doi: 10.1007/s00268-017-3985-8
|
| 89 |
Junzhang Huang, Ying Zhou, Suosu Wei, Yuntian Tang, Qiuhuan Zhang, Yi Tang, Wei Huang, Chongde Mo, Xiaofeng Dong, Jianrong Yang. The impact of tumor burden score on prognosis in patients after radical resection of hepatocellular carcinoma: a single-center retrospective study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1359017
|
| 90 |
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
|
| 91 |
Yongfu Xiong, Gang Yang, Kang Wang, Muhammad Riaz, Jian Xu, Zhenbing Lv, He Zhou, Qiang Li, Weinan Li, Ji Sun, Tang Tao, Jingdong Li. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00879
|
| 92 |
Erhua Yao, Jinghong Chen, Xiaofang Zhao, Yinyan Zheng, Xianheng Wu, Fei Han, Hecheng Huang, Ping Liang, Jianmin Liu, Fasheng Wu, Lianxing Lin. Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/5481909
|
| 93 |
Miao Chen, Duo Wang, Yuan Zhao, Dan‑Mei Lu, Hong‑Xue Li, Jun‑Jie Liu, Hang Li. Preoperative color Doppler ultrasonography predicts early recurrence in AFP‑positive hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10825
|
| 94 |
|
| 95 |
P. Hendriks, W. A. Noortman, T. R. Baetens, A. R. van Erkel, C. S. P. van Rijswijk, R. W. van der Meer, M. J. Coenraad, L. F. de Geus-Oei, C. H. Slump, M. C. Burgmans. Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/4049287
|
| 96 |
Xiuwei Yang, Jing Xie, Xiaoxiao Liu, Zichao Li, Kun Fang, Luying Zhang, Mei Han, Zhuang Zhang, Zhi Gong, Xuezhu Lin, Xianzhou Shi, Hui Gao, Kui Lu. Autophagy induction by xanthoangelol exhibits anti‐metastatic activities in hepatocellular carcinoma. Cell Biochemistry and Function 2019; 37(3): 128 doi: 10.1002/cbf.3374
|
| 97 |
Alessandro Cucchetti, Jianhong Zhong, Sarah Berhane, Hidenori Toyoda, KeQing Shi, Toshifumi Tada, Charing C.N. Chong, Bang-De Xiang, Le-Qun Li, Paul B.S. Lai, Giorgio Ercolani, Vincenzo Mazzaferro, Masatoshi Kudo, Matteo Cescon, Antonio Daniele Pinna, Takashi Kumada, Philip J. Johnson. The chances of hepatic resection curing hepatocellular carcinoma. Journal of Hepatology 2020; 72(4): 711 doi: 10.1016/j.jhep.2019.11.016
|
| 98 |
Hayato Abe, Kazu Shibutani, Shintaro Yamazaki, Tatsuo Kanda, Mitsuhiko Moriyama, Masahiro Okada, Masahiko Sugitani, Shingo Tsuji, Tadatoshi Takayama, Yukiyasu Okamura. Tumor stiffness measurement using magnetic resonance elastography can predict recurrence and survival after curative resection of hepatocellular carcinoma. Surgery 2023; 173(2): 450 doi: 10.1016/j.surg.2022.11.001
|
| 99 |
Jianguo Qiu, Shuting Chen, Hong Wu, Chengyou Du. The prognostic value of a classification system for centrally located liver tumors in the setting of hepatocellular carcinoma after mesohepatectomy. Surgical Oncology 2016; 25(4): 441 doi: 10.1016/j.suronc.2016.03.001
|
| 100 |
Jiarui Yang, Hao Liang, Kunpeng Hu, Zhiyong Xiong, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01790-6
|
| 101 |
Junji Ueda, Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Atsushi Hirakata, Youichi Kawano, Tetsuya Shimizu, Tomohiro Kanda, Hideyuki Takata, Eiji Uchida. Evaluation of the Impact of Preoperative Values of Hyaluronic Acid and Type IV Collagen on the Outcome of Patients with Hepatocellular Carcinoma After Hepatectomy. Journal of Nippon Medical School 2018; 85(4): 221 doi: 10.1272/jnms.JNMS.2018_85-34
|
| 102 |
Jianfei Tu, Zhongwei Zhao, Min Xu, Minjiang Chen, Qiaoyou Weng, Jiangmei Wang, Jiansong Ji. Retracted: LINC00707 contributes to hepatocellular carcinoma progression via sponging miR‐206 to increase CDK14. Journal of Cellular Physiology 2019; 234(7): 10615 doi: 10.1002/jcp.27737
|
| 103 |
Jiahui Li, Sudhakar Kundapur Venkatesh, Meng Yin. Advances in Magnetic Resonance Elastography of Liver. Magnetic Resonance Imaging Clinics of North America 2020; 28(3): 331 doi: 10.1016/j.mric.2020.03.001
|
| 104 |
Ruby Siu-Ting Lau, Philip Ip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Eugene Jun-Yee Lo, Kandy Kam-Cheung Wong, Andrew Kai-Yip Fung, John Wong, Kit-Fai Lee, Kelvin Kwok-Chai Ng, Paul Bo-San Lai, Henry Lik-Yuen Chan, Charing Ching-Ning Chong. Liver stiffness measurement predicts short-term and long-term outcomes in patients with hepatocellular carcinoma after curative liver resection. The Surgeon 2022; 20(2): 78 doi: 10.1016/j.surge.2021.01.004
|
| 105 |
Ya-yun Qian, You-yang Shi, Song-hua Lu, Ting Yang, Xue-yu Zhao, Yan Yan, Wen-yuan Li, Yan-qing Liu. Extracts of Celastrus Orbiculatus Inhibit Cancer Metastasis by Down-regulating Epithelial-Mesenchymal Transition in Hypoxia-Induced Human Hepatocellular Carcinoma Cells. Chinese Journal of Integrative Medicine 2019; 25(5): 334 doi: 10.1007/s11655-018-2562-9
|
| 106 |
Jinghua Lu, Yipei Ding, Wanqiu Zhang, Yuanyuan Qi, Jin Zhou, Naihan Xu, Yaou Zhang, Weidong Xie. SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma. Cells 2023; 12(9): 1238 doi: 10.3390/cells12091238
|
| 107 |
Jie Ji, Chun Zhou, Le-le Yan, Yuan Ma, Chuan Xu, Fu-an Wang, Wei-Zhong Zhou, Peng-hua Lv. Transarterial Chemoembolization Plus Tyrosinkinase Inhibitors and PD-1 Inhibitors for Spontaneously Ruptured Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2024; 47(3): 299 doi: 10.1007/s00270-023-03653-1
|
| 108 |
Kun Huang, Zhi Dong, Huasong Cai, Mengqi Huang, Zhenpeng Peng, Ling Xu, Yingmei Jia, Chenyu Song, Zi-Ping Li, Shi-Ting Feng. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5574-8
|
| 109 |
Meixiang Li, Xionghao Pang, Haixia Xu, Liang Xiao. CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p. Molecular Biotechnology 2024; doi: 10.1007/s12033-024-01054-4
|
| 110 |
Jin Wang, Qungang Shan, Yong Liu, Hao Yang, Sichi Kuang, Bingjun He, Yao Zhang, Jingbiao Chen, Tianhui Zhang, Kevin J. Glaser, Cairong Zhu, Jun Chen, Meng Yin, Sudhakar K. Venkatesh, Richard L. Ehman. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence. Journal of Magnetic Resonance Imaging 2019; 49(3): 719 doi: 10.1002/jmri.26250
|
| 111 |
Jin‐Min Kim, Seung‐Hyun Lee, Woo Young Shin, Keon‐Young Lee, Jun Mee Kim, Seung‐Ik Ahn. Intrahepatic recurrence of single nodular hepatocellular carcinoma after surgical resection: an analysis by segmental distribution. ANZ Journal of Surgery 2018; 88(12) doi: 10.1111/ans.14824
|
| 112 |
Jing-Houng Wang, Wei-Feng Li, Chee-Chien Yong, Yueh-Wei Liu, Sheng-Nan Lu, Chih-Chi Wang. Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85431-y
|
| 113 |
Hui Zhao, Chuang Chen, Shen Gu, Xiaopeng Yan, Wenjun Jia, Liang Mao, Yudong Qiu. Anatomical versus non‐anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis. Journal of Gastroenterology and Hepatology 2017; 32(4): 870 doi: 10.1111/jgh.13603
|
| 114 |
Deyuan Zhang, Jinyu Cao, Qingling Zhong, Liangtao Zeng, Chang Cai, Lang Lei, Wen Zhang, Fanrong Liu. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 95: 1187 doi: 10.1016/j.biopha.2017.09.045
|
| 115 |
Bon-Wook Koo, Dae-Jin Lim, Ah-Young Oh, Hyo-Seok Na. Retrospective Comparison between the Effects of Propofol and Inhalation Anesthetics on Postoperative Recurrence of Early- and Intermediate-Stage Hepatocellular Carcinoma. Medical Principles and Practice 2020; 29(5): 422 doi: 10.1159/000506637
|
| 116 |
Sheng Bao, Jinyang Gu, Kai Gan, Yuan Fang, Tao Wang, Jie Lin, Zhong Zeng, Hanfei Huang. Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e603 doi: 10.1097/MEG.0000000000002175
|
| 117 |
Jian Yin, Qian Liu, Chao Chen, Wenxiang Liu. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA‐5581‐3p/human cardiolipin synthase 1. Journal of Cellular Physiology 2019; 234(10): 17589 doi: 10.1002/jcp.28383
|
| 118 |
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Youngdong Choi, Kyung-Chul Choi. Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity. Molecules and Cells 2022; 45(12): 935 doi: 10.14348/molcells.2022.0105
|